|
|
| 0.52 Delayed Data As of Feb 27 |  -0.02 / -3.70%Today’s Change | 0.40 Today|||52-Week Range 0.93 | -7.14% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $82.7M |
Mast Therapeutics, Inc. 12390 El Camino Real San Diego California 92130 |
| Other institutional | 17.77% |
| Mutual fund holders | 10.33% |
| Individual stakeholders | 0.27% |
| Brian M. Culley | Chief Executive Officer & Director |
| Patrick L. Keran | President, Chief Operating Officer & Secretary |
| Brandi L. Roberts | Chief Financial Officer, CAO & Senior VP |
| Edwin L. Parsley | Chief Medical Officer & Senior Vice President |
| Robert Martin Emanuele | Senior Vice President-Development |
